National Health Investors (NHI) FFO Growth Challenges Bearish Margin And Tenant Risk Narratives

Simply Wall St.

Mar 01

National Health Investors (NHI) closed out FY 2025 with Q4 revenue of US$107.5 million and basic EPS of US$0.80, alongside funds from operations of US$58.5 million, which is a key earnings measure for...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2616984368"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2616984368\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2616984368?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/9621071-choice1-main-header/1585186852842","is_english":true,"pubTime":"2026-03-01 01:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2616984368","market":"us","top_or_hot":-1,"title":"National Health Investors (NHI) FFO Growth Challenges Bearish Margin And Tenant Risk Narratives","media":"Simply Wall St.","content":"<div>\n<p>National Health Investors (NHI) closed out FY 2025 with Q4 revenue of US$107.5 million and basic EPS of US$0.80, alongside funds from operations of US$58.5 million, which is a key earnings measure for...</p>\n\n<a href=\"https://simplywall.st/stocks/us/real-estate/nyse-nhi/national-health-investors/news/national-health-investors-nhi-ffo-growth-challenges-bearish\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>National Health Investors (NHI) FFO Growth Challenges Bearish Margin And Tenant Risk Narratives</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNational Health Investors (NHI) FFO Growth Challenges Bearish Margin And Tenant Risk Narratives\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-03-01 01:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/real-estate/nyse-nhi/national-health-investors/news/national-health-investors-nhi-ffo-growth-challenges-bearish><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>National Health Investors (NHI) closed out FY 2025 with Q4 revenue of US$107.5 million and basic EPS of US$0.80, alongside funds from operations of US$58.5 million, which is a key earnings measure for...</p>\n\n<a href=\"https://simplywall.st/stocks/us/real-estate/nyse-nhi/national-health-investors/news/national-health-investors-nhi-ffo-growth-challenges-bearish\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4203","symbol_name":"医疗保健房地产投资信托","start_time":0,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-nhi/national-health-investors/news/national-health-investors-nhi-ffo-growth-challenges-bearish","article_id":"2616984368","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/9621071-choice1-main-header/1585186852842"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-nhi/national-health-investors/news/national-health-investors-nhi-ffo-growth-challenges-bearish","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2616984368","pubTimestamp":1772299933,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"National Health Investors (NHI) closed out FY 2025 with Q4 revenue of US$107.5 million and basic EPS of US$0.80, alongside funds from operations of US$58.5 million, which is a key earnings measure for healthcare REIT investors. The company reported quarterly revenue of US$85.8 million in Q4 2024 and US$107.5 million in Q4 2025, while basic EPS moved from US$0.96 to US$0.80 over the same period, providing a view of how the top line and earnings per share have developed into the latest release...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4203":"医疗保健房地产投资信托","NHI":"National Health Investors","BK4225":"医疗保健房地产信托"},"translate_title":"国家健康投资者(NHI)FFO增长挑战看跌利润率和租户风险叙述","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NHI":1.5},"content_text":"National Health Investors (NHI) closed out FY 2025 with Q4 revenue of US$107.5 million and basic EPS of US$0.80, alongside funds from operations of US$58.5 million, which is a key earnings measure for healthcare REIT investors. The company reported quarterly revenue of US$85.8 million in Q4 2024 and US$107.5 million in Q4 2025, while basic EPS moved from US$0.96 to US$0.80 over the same period, providing a view of how the top line and earnings per share have developed into the latest release as markets assess growth potential alongside margin trends. See our full analysis for National Health Investors. With the latest numbers on the table, the next step is to compare this performance with the widely shared narratives around NHI to see which storylines the results support and which they call into question. See what the community is saying about National Health Investors NYSE:NHI Revenue & Expenses Breakdown as at Feb 2026 AdvertisementFFO and margins paint a mixed picture  On a trailing 12 month basis, NHI generated US$218.7 million in FFO and US$141.9 million in net income on US$379.3 million of revenue, with net profit margin at 37.4% compared with 41.1% a year earlier. Consensus narrative points to senior housing demand and SHOP segment growth as key supports for long term earnings, yet the slip in reported margin and commentary around near term occupancy softness show that higher demand does not automatically translate into steadily improving profitability.\n     Analysts expect earnings to reach about US$187.4 million with margins rising to 43.8% in a few years, while the latest trailing figures still sit at US$141.9 million and 37.4%. The margin uplift in that view has not appeared in the current numbers. Comments about labor strain and aging assets in secondary markets line up with the lower margin vs last year. This challenges the more bullish idea that asset management and acquisitions alone will steadily lift net operating income and profitability.    Bulls argue that NHI's senior housing exposure and SHOP growth can support a stronger profit profile over time, and these FY 2025 results give you a concrete baseline for comparing those expectations with what the business is actually earning right now. 🐂 National Health Investors Bull Case Revenue growth vs 37.4% margin  Revenue over the last 12 months reached US$379.3 million, up from US$335.6 million on a trailing basis a year earlier, while net profit margin moved from 41.1% to 37.4% in the same comparison. Skeptics highlight that tenant concentration, occupancy softness and higher operating needs could limit earnings predictability, and the combination of higher revenue with a lower margin gives some support to that cautious angle.\n     Operators such as Discovery and Bickford account for a meaningful share of NOI, so any weakness at a major tenant can show up as slower FFO growth even when portfolio level revenue is higher. Comments about abnormal move outs and potential capex for aging assets are consistent with a situation where more revenue does not prevent pressure on profitability, which is exactly what bears are concerned about.    Bears warn that margin pressure, tenant concentration and capital needs could limit how much of the top line turns into lasting FFO, and the FY 2025 data helps you see how that concern lines up with the current numbers. 🐻 National Health Investors Bear Case Valuation signals send mixed messages  NHI trades at a trailing P/E of 28.2x, above the Global Health Care REITs industry average of 26x but well below the peer average of 66.3x, and the provided DCF fair value of US$197.38 sits well above the current share price of US$84.07. Consensus narrative suggests growth in the 75+ population, a pipeline of senior housing investments and projected earnings growth of about 12.3% a year support the case that the stock is reasonably valued. At the same time, the higher than industry P/E and margin slippage mean the market is already paying up relative to some REIT peers while still weighing debt levels and dividend stability.\n     Analysts have a price target of US$85.63, only slightly above the current US$84.07 share price, which is a much more conservative view than the DCF fair value figure and shows how different valuation approaches can point to very different outcomes. Forecast revenue growth of roughly 11% a year and earnings growth around 12.3% are reflected in those valuation markers, so as a shareholder you can compare whether that growth profile and 37.4% margin feel sufficient for paying a P/E that is above the broader health care REIT industry.    Next Steps To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for National Health Investors on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves. If this mix of positives and concerns feels finely balanced, it is worth moving quickly to check the full picture for yourself. This includes 3 key rewards and 2 important warning signs. See What Else Is Out There NHI is generating revenue and FFO, but softer margins, tenant concentration and capital needs mean not all of that income looks especially resilient. If you are concerned that earnings quality and tenant risks could unsettle future returns, take a few minutes to review 77 resilient stocks with low risk scores that focus on stronger stability profiles.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if National Health Investors might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}